Reinforced Pancreaticojejunostomy With or Without glubran2

Recruiting now · Phase 2

Conditions studied: Pancreatic Fistula, Pancreas Cancer, Periampullary Carcinoma, Pancreatic Ductal Adenocarcinoma

In brief

Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .

Key facts

Study ID

NCT06756074

Run by

Minia University

People needed

100

Starts

2025-01-15

Expected to finish

2026-05-15

Last updated by the study team

2026-03-16

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All the patients undergoing pancreaticoduodenectomy for cancer
• Patients able to give their informed consent

You may not qualify if…

• Unfit patients for surgery due to severe medical illness.
• Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
• Presence of distant metastasis .
• Patients refused to participate in the study.

Where it is running

• Liver and GIT hospital / Minia university — Minya, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.